A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.

Saved in:

Bibliographic Details
Title:	A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.
Authors:	Wohlford GF; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Buckley LF; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Kadariya D; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Park T; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Chiabrando JG; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Carbone S; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Mihalick V; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Halquist MS; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Pearcy A; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Austin D; Serpin Pharma LLC, Manassas, Virginia, United States of America., Gelber C; Serpin Pharma LLC, Manassas, Virginia, United States of America., Abbate A; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Van Tassell B; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Source:	PloS one [PLoS One] 2021 May 06; Vol. 16 (5), pp. e0247357. Date of Electronic Publication: 2021 May 06 (Print Publication: 2021).
Publication Type:	Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
Journal Info:	Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One
Database:	MEDLINE Ultimate

Description
ISSN:	1932-6203
DOI:	10.1371/journal.pone.0247357